ARCHIVES

AACR Meeting: Celebrex Studies Show Benign Polyp Reduction, Point To Challenges In Biomarker Validation.

This article is from The Cancer Letter archive.

Vol. 32 No. 14 | April 14, 2006

Download PDF Visit The Full Archive

Related Articles

AVEO’s Tivozanib Sunk by Fundamental Flaw: Higher Overall Survival in the Control Arm

May 8, 2013

Funding opportunities listed.

November 19, 2004

NCI Releases 550 Pages of Internal Documents Related To Duke Scandal

January 7, 2011

Monica Bertagnolli To Succeed Schilsky As CALGB Chairman.

November 21, 2008

Overhead Caused By Outreach, Other Federal Programs Threatens Cancer Centers, Durant Contends

November 5, 1976

Interferon Alpha-2B Effective For Malignant Melanoma

July 27, 2001